Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01775085 · ClinicalTrials.gov registry record · NA

Group Interventions for Breast Cancer Survivors

A NA study of Breast Cancer Survivor, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
104
Enrollment target
2
Study locations

NCT01775085: Active NA study of Breast Cancer Survivor, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01775085 is a NA study of Breast Cancer Survivor that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 104 participants, above the 85-participant average among 5 other Breast Cancer Survivor trials with a reported enrollment target (22% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01775085, a NA study of Breast Cancer Survivor, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
104 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare two types of groups for breast cancer survivors: a Meaning-Centered Group and a Discussion Group. Many breast cancer survivors seek help to deal with the emotional burden of having gone through the cancer experience. Participation in groups offering support often helps cancer survivors cope with stressors of life after having had cancer by giving them a place to express their feelings. The "Meaning-Centered Group" is intended to teach breast cancer survivors how to maintain or even increase a sense of meaning and purpose in their lives after treatment for cancer. The "Discussion Group" is intended to help breast cancer survivors cope by giving them a place to get support from other breast cancer survivors. The goal of this study is to compare the benefits of these two types of group approaches for breast cancer survivors. The study is also testing the benefits and feasibility of conducting the groups virtually using a telephone and computer.

Conditions Studied

Interventions

  • BEHAVIORAL manualized group intervention
  • BEHAVIORAL standardized, manualized group intervention

Study Locations (2)

New York

  • Memorial Sloan Kettering Cancer Center at Commack - Commack
  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2013-01
Est. Completion 2027-01
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT01775085 still lists

NCT01775085 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, above the 85-participant average among 5 other Breast Cancer Survivor trials with a reported enrollment target (22% higher).

The record links to 1 condition, with Breast Cancer Survivor appearing as the primary indexed condition, and to 2 interventions - of which manualized group intervention is the first listed.

NCT01775085 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01775085 about?

NCT01775085 is a clinical study titled "Group Interventions for Breast Cancer Survivors". The purpose of this study is to compare two types of groups for breast cancer survivors: a Meaning-Centered Group and a Discussion Group. Many breast cancer survivors seek help to deal with the emotional burden of having gone through the cancer experience. Participation in groups offering support of...

What is the current status of trial NCT01775085?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2013-01. Estimated completion is 2027-01.

What conditions does trial NCT01775085 study?

This clinical trial studies the following conditions: Breast Cancer Survivor.

What interventions are being tested in trial NCT01775085?

The interventions under investigation include: manualized group intervention (BEHAVIORAL), standardized, manualized group intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01775085?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01775085 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer Survivor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01775085, the US trial registry maintained by the National Library of Medicine. NCT01775085 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.